Autosomal dominant polycystic kidney disease (ADPKD) Prostate Cancer
Conditions
Interventions
None listed
Sponsors
Endowed course for the study of polycystic kidney disease, Juntendo University, Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1: ADPKD 2: Newly diagnosed -prostate cancer patients who need hormonal therapy
Exclusion criteria
Exclusion criteria: 1: Taking antibiotics or Immunosuppressive agent 2: Past history of operation of intestinal (without Endoscopic surgery ) 3: Severe intestinal disease 4: Without Informed consent 5: Assessed as unsuitable as research subjects by medical doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metagenomic analysis and Metabolome analysis of Intestinal flora before, 2weeks, 1months, 3months, 6months, 12months | — |
Secondary
| Measure | Time frame |
|---|---|
| Renal function Kidney volume PSA | — |
Countries
Japan
Contacts
Public ContactHaruna Kawano
Juntendo University, Graduate School of Medicine Endowed course for the study of polycystic kidney disease
Outcome results
None listed